Genpharmasec Limited has submitted a regulatory filing to BSE Limited regarding an upcoming board meeting scheduled for Tuesday, 11th August 2026. The meeting will be held at the company's registered office located at 104 & 105, 1st Floor, Gundecha Industrial Premises Co-Operative Society Ltd., Akurli Road, Kandivali (East), Mumbai 400101.
The primary agenda items for the board meeting include:
- Consideration and approval of Un-audited Standalone Financial Results for the quarter ended 30th June, 2026
- Consideration and approval of Un-audited Consolidated Financial Results for the quarter ended 30th June, 2026
- Review and approval of the Limited Review Report for the quarter ended 30th June, 2026
- Consideration of any other business with the permission of the Chairman
The disclosure is made in accordance with Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Additionally, the company has implemented a trading window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct for Prevention of Insider Trading. The trading restriction period is effective from 1st July 2026 and will remain closed until 48 hours after the declaration of the Un-Audited Standalone and Consolidated Financial Results for the quarter ended 30th June 2026. This restriction applies to all Directors, Designated Persons, their immediate relatives, and specified Connected Persons.